Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved by UKCA for NHS & Private UK Clinics
December 05, 2024 04:02 ET
|
Magstim EGI
UKCA Approves Magstim Horizon Inspire TMS for NHS & Private UK Clinics. UK Made System for Patient Treatment of MDD, OCD and Decreasing Anxiety.
ADHD: What You Need to Know
November 19, 2024 10:00 ET
|
Brain & Behavior Research Foundation
New York, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Attention-Deficit Hyperactivity Disorder (ADHD) is one of the most common mental health disorders of childhood. On Wednesday, December 4, 2024, at 7 p.m....
Sparian Biosciences Awarded $19.5 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-226 for Opiate Use Disorder/ Opiate Withdrawal Syndrome Through Phase 1 Clinical Development
November 14, 2024 10:06 ET
|
Sparian Biosciences, Inc
Sparian Biosciences announced that it has been awarded a $19.5 million, five-year grant to fund development of SBS-226
Sparian Biosciences Announces Formation of its Science Advisory Board
November 13, 2024 13:01 ET
|
Sparian Biosciences, Inc
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Sparian Biosciences, Inc. (“Sparian”), a clinical-stage CNS-focused biopharmaceutical company, is proud to announce formation of a Science Advisory Board...
Sparian Biosciences Announces Results from the Phase 1 Clinical Trial of First in Class Novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000
November 12, 2024 10:01 ET
|
Sparian Biosciences, Inc
Sparian Biosciences announced results from the Phase 1 clinical trial of the first in class novel AEAr agonist analgesic SBS-1000.
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression
November 12, 2024 08:11 ET
|
Magstim EGI
FDA clears Magstim INSPIRE Transcranial Magnetic Stimulation TMS system to treat patients with Depression, OCD, Anxious Depression
Intergenerational Effects of Adversity on Mind-Body Health: Pathways Through the Gut-Brain Axis
November 07, 2024 11:41 ET
|
Brain & Behavior Research Foundation
New York, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Intergenerational Effects of Adversity on Mind-Body Health: Pathways...
Brain & Behavior Research Foundation International Mental Health Research Symposium Featuring Talks on Psychosis, Child and Adolescent Psychiatry, Mood Disorders and More
October 17, 2024 11:19 ET
|
Brain & Behavior Research Foundation
New York, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) International Mental Health Research Symposium will be held on Friday, October 25, 2024, at the...
Toward Brain-Based Prediction of Recovery: How Neuroimaging Can Help Combat the Substance-Use Epidemic
October 02, 2024 12:00 ET
|
Brain & Behavior Research Foundation
New York, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Toward Brain-Based Prediction of Recovery: How Neuroimaging Can Help...
PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA
October 02, 2024 09:20 ET
|
PharmAla Biotech
PharmAla Biotech signs contract to supply Harvard neuropsychiatry hospital with MDMA; Appears at CPHI Conference in Milan